+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Brain Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Fatty Pancreas - Pipeline Insight, 2024 - Product Thumbnail Image

Fatty Pancreas - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Blastic Plasmacytoid Dendritic cell neoplasm - Pipeline Insight, 2024 - Product Thumbnail Image

Blastic Plasmacytoid Dendritic cell neoplasm - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
TRK Fusion Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

TRK Fusion Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
MDS - Pipeline Insight, 2024 - Product Thumbnail Image

MDS - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HR-Positive-HER-negative - Pipeline Insight, 2024 - Product Thumbnail Image

HR-Positive-HER-negative - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Multiple myeloma-related bone disease - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple myeloma-related bone disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
PTCL-NOS - Pipeline Insight, 2024 - Product Thumbnail Image

PTCL-NOS - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CD19/CD20 Bi-Specific CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CD19/CD20 Bi-Specific CAR-T - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
T-Cell Prolymphocytic Leukemia (T-PLL) - Pipeline Insight, 2024 - Product Thumbnail Image

T-Cell Prolymphocytic Leukemia (T-PLL) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2024 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
DDR Defect Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

DDR Defect Tumors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Mucinous cystic neoplasm - Pipeline Insight, 2024 - Product Thumbnail Image

Mucinous cystic neoplasm - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Desmoplastic Small Round Cell Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Desmoplastic Small Round Cell Tumor - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Gastrointestinal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more